Ann: Research Report on NuSep , page-10

I can’t help but be pleasantly surprised by the Alpha Securities analyst’s research report. Since it was a commissioned report my expectation was not great, so that I didn’t even bother to read it immediately. However, it contains a wealth of information, reasonably carefully explained, including plans, projections, and much scientific data gathered up from years of experimentation. If you wanted to read a more complete story of how PrIME fits in with its competitors then here it is.

Even if, for the sake of argument, Nusep management had written this report themselves then it would be applauded as an excellent summary and explanation of the processes and relative merits of PrIME vis-a-vis the classical fractionators. Whatever Alpha have done, it has at least forced a comprehensive description of the comparative processes and the market parameters of the Nusep technology.

In one sense I am somewhat surprised at the level of detail of the Nusep business plan and strategy that is described. The prime purpose is probably intended for impressing potential stake holders in the subsidiary companies. One could imagine that it should also be read and pored over by the Big Fractionators for their own health. At the same time Nusep is presently so small that gnats are not normally even noticed.

I remember seeing various of the data sheets from around 10 years ago and had wondered what had happened to that information. Certainly there have been major staff changes in the time but the laws of Physics have not changed. The pentagram diagram by Bayer demonstrates some of the relative merits of fractionating processes. I suspect that some extra arms of characteristic merit could now be added that would further enhance the shine of PrIME.

I would strongly recommend that shareholders read this report in its entirety.

Juke